Drs. Karl and Spencer discuss the recent FLOW trial where semaglutide was found to be kidney protective. They also go off about the costs of these medicines and what to do (including compounding considerations).
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Fler avsnitt av Docs Who Lift
Visa alla avsnitt av Docs Who LiftDocs Who Lift med Docs Who Lift finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
